Parent Company Financial Information (Condensed Statements of Cash Flows, Parent Only) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Bargain purchase gain	$ (8,816)	$ 0
Amortization of debt issuance costs	122	122
Stock-based compensation expense	1,174	636
Bank owned life insurance income	(1,997)	(1,118)
Net (increase) decrease in other assets	(10,875)	(1,450)
Net (decrease) increase in other liabilities	(3,653)	(5,838)
Net cash provided by operating activities	22,713	52,647
Cash flows from investing activities:
Purchase of company owned life insurance	(249)	(10,165)
Net cash provided by (used in) investing activities	172,313	(581,572)
Cash flows from financing activities:
Common stock dividends paid	(12,733)	(9,530)
Issuance of common stock	385	386
Net cash provided by financing activities	121,888	811
Net increase (decrease) in cash and cash equivalents	316,914	(528,114)
Cash and cash equivalents at beginning of period	55,499	583,613
Cash and cash equivalents at end of period	372,413	55,499
Parent Company
Cash flows from operating activities:
Net Income	11,228	31,177
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Deficit (equity) in undistributed net income of subsidiaries	10,534	(29,521)
Bargain purchase gain	(8,816)	0
Amortization of debt issuance costs	122	122
Stock-based compensation expense	1,174	636
Bank owned life insurance income	(141)	(67)
Acquisition accounting adjustments	557	188
Net (increase) decrease in other assets	(1,267)	387
Net (decrease) increase in other liabilities	(682)	275
Net cash provided by operating activities	12,709	3,197
Cash flows from investing activities:
Purchase of company owned life insurance	(249)	0
Cash acquired in the acquisition of TCFC, net of cash paid	88	0
Net cash provided by (used in) investing activities	(161)	0
Cash flows from financing activities:
Common stock dividends paid	(12,733)	(9,530)
Issuance of common stock	385	386
Net cash provided by financing activities	(12,348)	(9,144)
Net increase (decrease) in cash and cash equivalents	200	(5,947)
Cash and cash equivalents at beginning of period	7,145	13,092
Cash and cash equivalents at end of period	$ 7,345	$ 7,145